Medicines Australia and AusBiotech say COVID-19 vaccine patent waiver will not speed up global vaccination

Medicines Australia

15 September 2021 - Medicines Australia and AusBiotech, the peak bodies representing the Australian innovative pharmaceutical and biotechnology sectors, urge the Australian Government not to support a proposed patent waiver for COVID-19 vaccines and therapies, as it will not help global vaccination.

The proposed patent waiver at the World Trade Organization, also known as the TRIPS waiver (Trade-Related Aspects of Intellectual Property Rights waiver), is a form of forced technology transfer or compulsory acquisition of intellectual property that would undermine the global vaccination effort rather than strengthen it.

Read Medicines Australia press release

Michael Wonder

Posted by:

Michael Wonder